Physician profile
Amanda Vest
NPI 1831365626
$3,663.51
in general payments reported to CMS, 2019-2025
10 companies · $755 in 2025
The $755 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,100 · 2022: $30.31 · 2023: $149 · 2024: $629 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,533.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,100.00 | 2019 | |
| Abbott Laboratories | $729.24 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Endotronix, INC. | $272.42 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Impulse Dynamics (USA) INC. | $157.86 | 2024-2025 | Optimizer |
| Scpharmaceuticals INC. | $141.78 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $117.66 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.24 | 2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.31 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Vest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.